Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function

Aging Male

Volumn 18, Issue 3, 2015, Pages 201-204

  Golan, Ron ^a   Scovell, Jason M ^b   Ramasamy, Ranjith ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; hypogonadism; late onset hypogonadism; testosterone

Indexed keywords

TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; DISEASE ASSOCIATION; GROUPS BY AGE; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TESTIS; TESTOSTERONE BLOOD LEVEL; BLOOD; HORMONE SUBSTITUTION; MALE; PHYSIOLOGY;

AGING; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; TESTIS; TESTOSTERONE;

EID: 84942511748     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2015.1052392     Document Type: Review

References (37)

1. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737-45.
2. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002; 87: 589-98.
3. Morley JE, Kaiser FE, Perry HM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410-13.
4. Harman SM, Metter EJ, Tobin JD, et al. Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724-31.
5. Dabaja AA, Bryson CF, Schlegel PN, Paduch DA. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density. BJU Int 2015; 115: 480-5.
6. Ramasamy R, Wilken N, Scovell JM, et al. Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men. Urology 2014; 84: 1378-82.
7. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-35.
8. Lackner JE, Rucklinger E, Schatzl G, et al. Are there symptom-specific testosterone thresholds in aging men? BJU Int 2011; 108: 1310-15.
9. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335-43.
10. Scovell JM, Ramasamy R, Wilken N, et al. Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/dL. BJU Int 2015. [Epub ahead of print]. doi: 10.1111/bju.12970.
11. Bhasin S, Cunningham GR, Hayes FJ, et al. Endocrine Society Task Force. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-59.
12. Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010; 95: 1810-18.
13. Scott HM, Mason JI, Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev 2009; 30: 883-925.
14. Rubens R, Dhont M, Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1974; 39: 40-5.
15. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR. Age-related decreased Leydig cell testosterone production in the brown Norway rat. J Androl 1994; 15: 551-7.
16. Neaves WB, Johnson L, Porter JC, et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984; 59: 756-63.
17. Sasano N, Ichijo S. Vascular patterns of the human testis with special reference to its senile changes. Tohoku J Exp Med 1969; 99: 269-80.
18. Takizawa T, Hatakeyama S. Age-associated changes in microvasculature of human adult testis. Acta Pathol Jpn 1978; 28: 541-54.
19. Regadera J, Nistal M, Paniagua R. Testis, epididymis, and spermatic cord in elderly men. Correlation of angiographic and histologic studies with systemic arteriosclerosis. Arch Pathol Lab Med 1985; 109: 663-7.
20. Beattie MC, Adekola L, Papadopoulos V, et al. Leydig cell aging and hypogonadism. Exp Gerontol 2015. [Epub ahead of print]. doi: 10.1016/j.exger.2015.02.014.
21. Araujo AB, Wittert GA. Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab 2011; 25: 303-19.
22. Takahashi PY, Liu PY, Roebuck PD, et al. Graded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflow. J Clin Endocrinol Metab 2005; 90: 2768-74.
23. Gruenewald DA, Naai MA, Marck BT, Matsumoto AM. Age-related decrease in hypothalmic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male brown Norway rat. J Andrology 2000; 21: 72-84.
24. Urban RJ, Veldhuis JD, Blizzard RM, Dufau ML. Attenuated release of biologically active luteinizing hormone in healthy aging men. J Clin Invest 1988; 81: 1020-9.
25. Veldhuis JD, Urban RJ, Lizarralde G, et al. Attenuation of luteinizing-hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992; 75: 52-8.
26. Kaler LW, Critchlow V. Anterior-pituitary luteinizing-hormone secretion during continuous perifusion in aging male-rats. Mech Ageing Dev 1984; 25: 103-15.
27. Winters SJ, Sherins RJ, Troen P. The gonadotropin-suppressive activity of androgen is increased in elderly men. Metab Clin Exp 1984; 33: 1052-9.
28. Molnar CS, Vida B, Sipos MT, et al. Morphological evidence for enhanced kisspeptin and neurokinin B signaling in the infundibular nucleus of the aging man. Endocrinology 2012; 153: 5428-39.
29. Darby E, Anawalt BD. Male hypogonadism: an update on diagnosis and treatment. Treat Endocrinol 2005; 4: 293-309.
30. Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf) 2012; 77: 755-63.
31. Camacho EM, Huhtaniemi IT, O'Neill TW, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013; 168: 445-55.
32. European Association of Urology. Guidelines on male hypogonadism. March 2015. Available from: http://uroweb.org.
33. Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015; 18: 5-15.
34. Administration USFaD. Advisory committee industry briefing document: testosterone replacement therapy. Available from: http://FDA.gov [last accessed 17 Sep 2014].
35. US Food and Drug Administration. Testosterone products: drug safety communication-FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke. Available from: http://FDA.gov [last accessed 3 March 2015].
36. Perls T, Handelsman DJ. Disease mongering of age-associated declines in testosterone and growth hormone levels. J Am Geriatr Soc 2015; 63: 809 - 11.
37. Snyder PJ, Ellenberg SS, Cunningham GR, et al. The testosterone trials: seven coordinated trials of testosterone treatment in elderly men. Clin Trials 2014; 11: 362-75